Shijiazhuang Yiling Pharmaceutical Says Subsidiary's Irbesartan Approved

About this update from Shijiazhuang Yiling Pharmaceutical Co., Ltd. Class A

Shijiazhuang Yiling Pharmaceutical Co Ltd SZSE:002603:SAYS SUBSIDIARY RECEIVED NATIONAL MEDICAL PRODUCTS ADMINISTRATION'S APPROVAL FOR IRBESARTAN

View stock analysis, news, and events for Shijiazhuang Yiling Pharmaceutical Co., Ltd. Class A